COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 1419: Articles 14181-14190  | Next

A novel RT-LAMP workflow for rapid salivary diagnostics of COVID-19 and effects of age, gender and time from symptom onset
Kobayashi, G. S., Brito, L. A., Moreira, D. D. P., Suzuki, A. M., Hsia, G. S. P., Pimentel, L. F., Barreto de Paiva, A. P., Dias, C. R., Lourenco, N. C. V., Oliveira, B. A., Manuli, E. R., Corral, M. A., Cavacana, N., Neto, M. M., Sales, M. M., Dell' Aquila, L. P., Filho, A. R., Parrillo, E. F., Mendes-Correa, M. C., Sabino, E. C., Costa, S. F., Leal, F. E., Sgro, G. G., Farah, C. S., Zatz, M., Passos-Bueno, M. R.
10.1101/2021.06.07.21258288 — Posted: 2021-06-09
Single-dose mRNA vaccine effectiveness against SARS-CoV-2, including P.1 and B.1.1.7 variants: a test-negative design in adults 70 years and older in British Columbia, Canada
Skowronski, D. M., Setayeshgar, S., Zou, M., Prystajecky, N., Tyson, J. R., Galanis, E., Naus, M., Patrick, D. M., Sbihi, H., El Adam, S., Henry, B., Hoang, L. M. N., Sadarangani, M., Jassem, A. N., Krajden, M.
10.1101/2021.06.07.21258332 — Posted: 2021-06-09
Bovine Colostrum Derived Antibodies Against SARS-CoV-2 Show Great Potential to Serve as a Prophylactic Agent
Kangro, K., Kurashin, M., Gildemann, K., Sankovski, E., Zusinaite, E., Lello, L. S., Pert, R., Kavak, A., Poikalainen, V., Lepasalu, L., Kuusk, M., Pau, R., Piiskop, S., Rom, S., Oltjer, R., Tiirik, K., Kogermann, K., Plaas, M., Tiirats, T., Aasmae, B., Plaas, M., Krinka, D., Talpsep, E., Kadaja, M., Gerhold, J. M., Planken, A., Tover, A., Merits, A., Mannik, A., Ustav, M., Ustav, M.
10.1101/2021.06.08.21258069 — Posted: 2021-06-09 Discussion: Onsite
Relevance of prediction scores derived from the SARS-CoV-2 first wave, in the UK COVID-19 second wave, for early discharge, severity and mortality: a PREDICT COVID UK prospective observational cohort study
Ghani, H., Navarra, A., Pyae, P. K., Mitchell, H., Evans, W., Cama, R., Shaw, M., Critchlow, B., Vaghela, T., Schechter, M., Nordin, N., Barlow, A., Vancheeswaran, R.
10.1101/2021.06.09.21258602 — Posted: 2021-06-09
A multi-component, community-based strategy to facilitate COVID-19 vaccine uptake among Latinx populations: from theory to practice
Marquez, C., Kerkhoff, A. D., Naso, J., Contreras, M. G., Castellanos, E., Rojas, S., Peng, J., Rubio, L., Jones, D., Jacobo, J., Rojas, S., Gonzalez, R., Fuchs, J. D., Black, D., Ribeiro, S., Nossokoff, J., Tulier-Laiwa, V., Martinez, J., Chamie, G., Pilarowski, G., DeRisi, J., Petersen, M., Havlir, D. V.
10.1101/2021.06.07.21258230 — Posted: 2021-06-09
The mental health impact of COVID-19 racial and ethnic discrimination against Asian American and Pacific Islanders
Zhou, S., Banawa, R., Oh, H.
10.1101/2021.06.06.21258177 — Posted: 2021-06-09
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby, P. W., Pessoa-Amorim, G., Staplin, N., Emberson, J. R., Spata, E., Campbell, M., Peto, L., Brunskill, N., Tiberi, S., Chew, V., Brown, T., Tahir, H., Ebert, B., Chadwick, D. R., Whitehouse, T., Sarkar, R., Graham, J. C., Baillie, J. K., Basnyat, B., Buch, M. H., Chappell, L. C., Day, J. N., Faust, S. N., Hamers, R., Jaki, T., Jeffery, K., Juszczak, E., Lim, W. S., Montgomery, A., Mumford, A., Rowan, K., Thwaites, G., Mafham, M., Haynes, R., Landray, M. J.
10.1101/2021.06.08.21258132 — Posted: 2021-06-08 Discussion: Onsite
Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection
Ramon, A. C., Perez, G. V., Caballero, E., Rosales, M., Aguilar, D., Vazquez-Blomquist, D. M., Ramos, Y., Rodriguez, A., Falcon, V., Rodriguez, M. P., Ke, Y., Perera, Y., Perea, S. E.
10.1101/2021.06.08.447588 — Posted: 2021-06-08
Predicted Coronavirus Nsp5 Protease Cleavage Sites in the Human Proteome: A Resource for SARS-CoV-2 Research
Scott, B. M., Lacasse, V., Blom, D. G., Tonner, P. D., Blom, N. S.
10.1101/2021.06.08.447224 — Posted: 2021-06-08
Single domain shark VNAR antibodies neutralize SARS-CoV-2 infection in vitro
Gauhar, A., Privezentzev, C. V., Demydchuk, M., Gerlza, T., Rieger, J., Kungl, A. J., Walsh, F. S., Rutkowski, J. L., Stocki, P.
10.1101/2021.06.08.447530 — Posted: 2021-06-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).